JP2023512823A5 - - Google Patents
Info
- Publication number
- JP2023512823A5 JP2023512823A5 JP2022548109A JP2022548109A JP2023512823A5 JP 2023512823 A5 JP2023512823 A5 JP 2023512823A5 JP 2022548109 A JP2022548109 A JP 2022548109A JP 2022548109 A JP2022548109 A JP 2022548109A JP 2023512823 A5 JP2023512823 A5 JP 2023512823A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- alkoxy
- hydrogen
- hydrocarbyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062970425P | 2020-02-05 | 2020-02-05 | |
| US62/970,425 | 2020-02-05 | ||
| PCT/US2021/016848 WO2021158936A1 (en) | 2020-02-05 | 2021-02-05 | Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023512823A JP2023512823A (ja) | 2023-03-29 |
| JP2023512823A5 true JP2023512823A5 (cg-RX-API-DMAC7.html) | 2025-03-21 |
| JP7678595B2 JP7678595B2 (ja) | 2025-05-16 |
Family
ID=77199407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548109A Active JP7678595B2 (ja) | 2020-02-05 | 2021-02-05 | ピロロ[2,3‐b]ピリジン‐3‐カルボキサミド組成物及び聴力損失を改善するための方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12617785B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4100008B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7678595B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115515579B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021215925B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3170121A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3025983T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX428671B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021158936A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115515579B (zh) | 2020-02-05 | 2025-09-30 | 洛克菲勒大学 | 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法 |
| EP4380562A4 (en) * | 2021-08-02 | 2025-05-21 | The Rockefeller University | PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELL PROLIFERATION |
| EP4687896A1 (en) * | 2023-04-04 | 2026-02-11 | Children's Hospital Los Angeles | Lats kinase inhibitor to treat retinal degeneration |
| WO2026010871A1 (en) * | 2024-07-01 | 2026-01-08 | Hudspeth A James | ((pyrrolopyridine-3-carbonyl) imino)-2,3-dihydrothiazol-4-yl) methyl phosphates for activating yap |
| KR20260029093A (ko) * | 2024-08-23 | 2026-03-04 | 한국화학연구원 | 카이네이즈 억제제 |
| WO2026043170A1 (ko) * | 2024-08-23 | 2026-02-26 | 한국화학연구원 | 카이네이즈 억제제 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1532980A1 (en) | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| FR2888848B1 (fr) * | 2005-07-22 | 2007-09-28 | Sanofi Aventis Sa | Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
| WO2007067537A1 (en) * | 2005-12-07 | 2007-06-14 | Osi Pharmaceuticals, Inc. | Pyrrolopyridine kinase inhibiting compounds |
| PE20121126A1 (es) * | 2006-12-21 | 2012-08-24 | Plexxikon Inc | Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa |
| KR101591153B1 (ko) | 2010-12-20 | 2016-02-02 | 그렌마크 파머수티칼스 에스. 아. | Trpa1 길항제로서의 2-아미노-4-아릴티아졸 화합물 |
| TWI667233B (zh) * | 2013-12-19 | 2019-08-01 | 德商拜耳製藥公司 | 新穎吲唑羧醯胺,其製備方法、含彼等之醫藥製劑及其製造醫藥之用途 |
| GB201602854D0 (en) * | 2016-02-18 | 2016-04-06 | Mission Therapeutics Ltd | Novel compounds |
| JOP20190257A1 (ar) * | 2017-04-28 | 2019-10-28 | Novartis Ag | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats |
| CN115515579B (zh) | 2020-02-05 | 2025-09-30 | 洛克菲勒大学 | 吡咯并[2,3-b]吡啶-3-甲酰胺组合物和改善听力损失的方法 |
-
2021
- 2021-02-05 CN CN202180019399.6A patent/CN115515579B/zh active Active
- 2021-02-05 JP JP2022548109A patent/JP7678595B2/ja active Active
- 2021-02-05 ES ES21750999T patent/ES3025983T3/es active Active
- 2021-02-05 WO PCT/US2021/016848 patent/WO2021158936A1/en not_active Ceased
- 2021-02-05 CA CA3170121A patent/CA3170121A1/en active Pending
- 2021-02-05 EP EP21750999.1A patent/EP4100008B1/en active Active
- 2021-02-05 AU AU2021215925A patent/AU2021215925B2/en active Active
- 2021-02-05 US US17/760,143 patent/US12617785B2/en active Active
- 2021-02-05 MX MX2022009572A patent/MX428671B/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2810852T3 (es) | Compuestos y composiciones para inhibir la actividad de shp2 | |
| US20240374595A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| US12006328B2 (en) | Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto | |
| JP2021534124A5 (cg-RX-API-DMAC7.html) | ||
| AU2013262320B2 (en) | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions | |
| JP5822840B2 (ja) | 眼疾患処置薬 | |
| CA2571347A1 (en) | Piperazine derivatives for the treatment of female sexual disorders | |
| RU2557982C2 (ru) | Композиции и способы ингибирования пути jak | |
| JP2005536475A5 (cg-RX-API-DMAC7.html) | ||
| JP2007519649A5 (cg-RX-API-DMAC7.html) | ||
| CN107660202B (zh) | 水溶性前药 | |
| BR112021006033A2 (pt) | Uso de um inibidor de um transportador da família ent no tratamento de câncer e combinação do mesmo com um antagonista do receptor de adenosina | |
| CN109069461A (zh) | 与髓源性抑制细胞相关的病症的治疗方法 | |
| JP2023512828A (ja) | クロマカリムプロドラッグ療法のための改善された方法及び組成物 | |
| RU2012147511A (ru) | Применение ингибиторов c-src в комбинации с пиримидиламинобензамидом для лечения лейкоза | |
| JP2004525183A5 (cg-RX-API-DMAC7.html) | ||
| PT1948176E (pt) | Diaril ureias para tratar a hipertensão pulmonar | |
| TW202114991A (zh) | 離胺醯氧化酶之二氟鹵烯丙胺碸衍生物抑制劑、製備方法、及其用途 | |
| JP2008543781A5 (cg-RX-API-DMAC7.html) | ||
| KR102792934B1 (ko) | 세페타프로스트와 Rho 키나아제 저해제의 조합 의약 | |
| JP4933897B2 (ja) | 眼内移行性促進水性点眼剤 | |
| JP2022519274A5 (cg-RX-API-DMAC7.html) | ||
| JP2009514910A (ja) | 肺高血圧を処置するためのジアリールウレア | |
| US20230046317A1 (en) | Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer | |
| JP2023550902A5 (cg-RX-API-DMAC7.html) |